About Steven M Smith
Steven Smith is an Assistant Professor in the Department of Pharmaceutical Outcomes and Policy, with a joint appointment in the Division of Cardiovascular Medicine (College of Medicine). He also serves as Associate Director for the UF Center for Integrative Cardiovascular and Metabolic Diseases.
He received his PharmD degree from the University of Florida College of Pharmacy. He then completed a PGY-1 residency at the North Florida/South Georgia Veterans Health System in Gainesville, FL. After his residency, Dr. Smith completed a postdoctoral fellowship in Family Medicine during which time he participated in the Advanced Postgraduate Program in Clinical Investigation (APPCI) and concurrently completed the requirements for a Master of Public Health. Dr. Smith joined the faculty at the University of Colorado in 2011. He returned to the University of Florida in 2014.
Dr. Smith’s research is in the area of cardiovascular pharmacotherapy and hypertension and is funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health. He is a member of the American Heart Association, American College of Cardiology, American College of Clinical Pharmacy, the American Association of Colleges of Pharmacy and the International Society for Pharmacoepidemiology. He also serves in several leadership roles nationally, including on the Examination Committee for the American Society of Hypertension Specialists’ Program (ASHSP) Certified Hypertension Clinician program, in several initiatives through the American Heart Association Hypertension Council, on the Board of Directors for the Consortium for Southeastern Hypertension Control, and as a founding member of the CDC’s National Hypertension Control Roundtable.
Dr. Smith also co-directs the UF Family Medicine Pharmacy Fellowship (see link below).
Board-Certified Pharmacotherapy SpecialistBoard of Pharmaceutical Specialties
Certified Hypertension ClinicianAmerican Hypertension Specialist Certification Program
Dr. Smith’s research lab focuses on understanding and improving use of cardiovascular-related drug therapy in the real world to reduce risk of major adverse outcomes at the population level. Hypertension and its treatment are the major area of focus, and Dr. Smith has particular expertise in the area of difficult-to-control, or ‘resistant’ hypertension.
His lab employs a variety of observational methodologic approaches and data sources, including EHR, administrative claims, and prospective cohort and randomized clinical trial data. Strong collaborations within the College of Pharmacy include with faculty and trainees in the Cardiovascular group of the Department of Pharmacotherapy and Translational Research, as well as with the Department of Pharmaceutical Outcomes and Policy and the Center for Drug Evaluation and Safety. Outside of the College, Dr. Smith’s group works closely with the Division of Cardiovascular Medicine and the Center for Integrative Cardiovascular and Metabolic Diseases, where Dr. Smith serves as Associate Director.
Current funding for the lab is through the National Heart, Lung and Blood Institute (NIH), and is focused on using integrated EHR and claims data to better understand what drives antihypertensive prescribing and effectiveness/safety issues with such drugs in the real world, and to use that information in developing predictive models for improving selection of initial antihypertensive therapy.
- Cardiometabolic Disease
- Cardiovascular Epidemiology
- Resistant Hypertension